Cite
HARVARD Citation
Wang, K. et al. (2022). Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway. Journal of cardiovascular pharmacology. 79 (2), pp. 217-228. [Online].